Neurology: Neuroimmunology and Neuroinflammation; Neurology; Current Treatment Options in Neurology (spouse)
Patents
Patent for Ma2 autoantibody test: "Ma family polypeptides and anti-Ma antibodies" (inventors Posner, Dalmau, Rosenfeld). USA Patent Number: US6387639; issued May 14th, 2002. Licensed to Athena Diagnostics, USA. Patent for NMDA receptor autoantibody test: "Methods and compositions for treatment and diagnosis of autoimmune encephalitis or epilepsy"(inventors: Dalmau, Rosenfeld, Lynch). USA Patent Number: US7972796B2; issued July 5th, 2011. European Patent Number: EP2057466B1, Issued Oct 23, 2013. Also issued in Canada, China. Licensed to Euroimmun AG, Germany. Patent for GABAb receptor autoantibody test: "Methods for diagnosing and treating encephalitis or epilepsy" (inventor: Dalmau). USA Patent Number: US8685656B2, issued April 1, 2014. European Patent Number: 2483417A4, issued March 29, 2017. Also issued in Denmark, Canada. Licensed to Euroimmun AG. Patent for DPPX receptor autoantibody test:"Diagnostic method for detecting a new form of autoimmune encephalitis and related subject-matter"(inventor: Dalmau). USA Patent Number: US9719993B2, issued Aug 1, 2017; European Patent Number: EP2895507B1, issued Nov 14, 2018. Licensed to Euroimmun AG. Patent for GABAa receptor autoantibody test: "Diagnostic method for detecting a GABA(A) related autoimmune disease and related subject-matter" (inventor: Dalmau). European Patent Number: EP3058376A1, issued Nov 27, 2019. Also issued in Denmark, China. Licensed to Euroimmun AG. Patent for IgLON5 autoantibody test: "Diagnosis of a neurologic disease" (inventors: Graus, Dalmau). European Patent Number: EP3102949B1, issued Oct 28, 2020. USA Patent Number: US10962554B2, issued Mar 30, 2021. Also issued in Denmark, China. Licensed to Euroimmun AG.
-SAGE Therapeutics, research support -Euroimmun, Inc, research support
Research Support, Government Entities
-Instituto Carlos III/FEDER (FIS PI20/00197, CIBERER Acciones Cooperativas y Complementarias Intramurales) -ERA-NET NEURON with Instituto Carlos III (AC18/00009 and AC21_2/00053)
Research Support, Academic Entities
-University of Utah (support for serving as a clinical trial site for a phase III study to evaluate Inebilizumab in anti-NMDARe)
Research Support, Foundations and Societies
-Edmond J Safra Foundation, research support -Cellex Foundation, research support -La Caixa Foundation Health Foundation, research support -Pablove Foundation Childhood Cancer, research support
Royalty Payments, Technology or Inventions
Ma2 autoantibody test (tech/invention), Athena Diagostics via Memoral Sloan Kettering, not currently generating income NMDA receptor, GABA(B) receptor autoantibody tests (tech/invention), Euroimmun, Inc via University of Pennsylvania, current (also to spouse) GABA(A) receptor, DPPX and IgLON5 autoantibody tests (tech/invention), Euroimmun, Inc via Institucio Catalana de Recerca i Estudis Avancats (ICREA); Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), current
